Our Pricing

Who Will Prescribe Mounjaro With Gallstones in the UK?

Published: 11 September 2026

Many patients wonder who will prescribe mounjaro with gallstones, particularly when they have a history of gallbladder disease or cholecystectomy. At Cured Pharmacy, our UK-registered clinical team assesses each patient individually, considering gallstone history alongside other eligibility criteria for tirzepatide treatment. Mounjaro (tirzepatide) is not absolutely contraindicated in patients with a history of gallstones, but prescribers must carefully evaluate the risk-benefit profile on a case-by-case basis, as rapid weight loss can increase gallstone formation risk.

Who Will Prescribe Mounjaro With Gallstones: UK Clinical Assessment

The question of who will prescribe mounjaro with gallstones depends on individual clinical assessment by a qualified UK prescriber. At Cured Pharmacy, our clinical team includes GPhC-registered pharmacists and prescribers who evaluate your full medical history during the online consultation process. Mounjaro (tirzepatide) is not listed as absolutely contraindicated in patients with a history of gallstones in the Summary of Product Characteristics (SmPC) approved by the MHRA [1].

However, prescribers must consider that rapid weight loss—a common outcome with tirzepatide treatment—can increase the risk of gallstone formation and biliary complications [2]. In the SURPASS clinical trial programme, cholelithiasis (gallstones) was reported in approximately 1-2% of tirzepatide-treated patients, though most cases were asymptomatic and detected incidentally [1]. Patients who have had their gallbladder removed (cholecystectomy) may be considered lower risk, as they cannot develop new gallstones, though bile duct stones remain a theoretical concern.

Our prescribers at Cured Pharmacy assess your gallstone history, whether you still have your gallbladder, any history of biliary colic or pancreatitis, current symptoms, and your overall weight loss goals. Subject to prescriber approval, many patients with a past history of gallstones or cholecystectomy can be safely prescribed Mounjaro from £124.99, with ongoing monitoring for any abdominal symptoms.

Mounjaro Prescribing Criteria for Patients Who Will Prescribe Mounjaro With Gallstones

When determining who will prescribe mounjaro with gallstones, UK clinicians follow NICE and MHRA guidance on tirzepatide eligibility, adapted for individual risk factors. The standard eligibility criteria include a BMI of 30 kg/m² or above (or 27 kg/m² with weight-related comorbidities), alongside a commitment to lifestyle modification [3]. Gallstone history is not an automatic exclusion, but prescribers will consider several factors.

Active symptomatic gallstones, recent biliary colic episodes, or acute cholecystitis within the past six months may prompt a prescriber to defer treatment until the gallbladder condition is managed, often through cholecystectomy. Patients with asymptomatic gallstones detected on imaging but no history of pain or complications are often considered suitable candidates, as the benefits of weight loss may outweigh the small increased risk of gallstone-related events [2]. Those who have already undergone cholecystectomy are generally at lower risk for gallstone complications, though prescribers will still assess for any history of bile duct stones or pancreatitis.

Risk-Benefit Assessment in Gallstone History

UK prescribers who will prescribe mounjaro with gallstones perform a thorough risk-benefit analysis. Obesity itself is a significant risk factor for gallstone formation, and weight loss—whether through medication, diet, or surgery—can paradoxically increase short-term gallstone risk due to changes in bile composition and gallbladder motility [2]. However, sustained weight loss reduces long-term cardiovascular and metabolic risks, which often justifies careful use of tirzepatide even in patients with gallstone history. Our clinical team at Cured Pharmacy provides clear safety advice and encourages patients to report any right upper quadrant pain, nausea, or jaundice immediately during treatment.

How Mounjaro Affects Gallstone Risk: Who Will Prescribe Mounjaro With Gallstones Safely

Understanding how tirzepatide influences gallstone risk helps clarify who will prescribe mounjaro with gallstones responsibly. Mounjaro works as a dual GIP/GLP-1 receptor agonist, slowing gastric emptying and promoting significant weight loss—patients in the SURMOUNT-1 trial achieved average weight reductions of up to 22.5% at the highest dose over 72 weeks [4]. Rapid weight loss, particularly at rates exceeding 1.5 kg per week, is associated with increased gallstone formation due to bile supersaturation with cholesterol and reduced gallbladder contractility [2].

Despite this theoretical risk, the absolute incidence of symptomatic gallstones in tirzepatide trials remained low, and most events were managed conservatively or with elective cholecystectomy [1]. Prescribers mitigate risk by starting at the lowest dose (2.5 mg weekly) and titrating gradually, which moderates the rate of weight loss. Patients with gallstone history are advised to maintain adequate hydration, avoid very-low-calorie diets, and report any abdominal pain promptly. At Cured Pharmacy, our prescribers who will prescribe mounjaro with gallstones ensure you understand these precautions and provide ongoing clinical support throughout your treatment journey.

Monitoring and Safety Protocols

Patients prescribed Mounjaro with a gallstone history benefit from structured monitoring. Our clinical team recommends follow-up assessments at 4, 8, and 12 weeks to review weight loss trajectory, tolerability, and any new symptoms. If right upper quadrant pain, persistent nausea, or signs of biliary obstruction develop, we advise immediate medical review and may pause or discontinue treatment pending investigation. This individualised approach ensures that who will prescribe mounjaro with gallstones does so with appropriate safeguards in place.

Alternative Weight Loss Options: Who Will Prescribe Mounjaro With Gallstones vs Other Treatments

For patients concerned about who will prescribe mounjaro with gallstones, it is helpful to understand alternative weight loss treatments and their gallstone risk profiles. Semaglutide (Wegovy) is another GLP-1 receptor agonist with a similar mechanism and weight loss efficacy, and it carries a comparable risk of gallstone-related events during rapid weight loss [5]. Liraglutide (Saxenda) produces more modest weight loss (average 5-8% in the SCALE trials) and may carry a slightly lower gallstone risk due to slower weight reduction, though this has not been definitively established [5].

Orlistat, a lipase inhibitor available at Cured Pharmacy from £124.99, works by reducing dietary fat absorption and typically results in gradual weight loss of 5-10% over six months. Because weight loss with orlistat is generally slower and less pronounced, the acute gallstone risk may be lower, making it an option for patients with significant gallstone concerns who prefer a non-injection treatment [3]. However, orlistat's gastrointestinal side effects and more modest efficacy mean it may not be suitable for patients requiring substantial weight reduction.

Who Will Prescribe Mounjaro With Gallstones: Cured Pharmacy's Clinical Approach

At Cured Pharmacy, our answer to who will prescribe mounjaro with gallstones is clear: our UK-registered clinical team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), assesses every patient individually. We do not apply blanket exclusions based solely on gallstone history. Instead, we conduct a thorough online consultation that reviews your gallbladder status, symptom history, previous imaging, surgical history, and overall health profile.

Our prescribers have access to your full medical questionnaire and can request additional information or recommend GP liaison if needed. If you have had a cholecystectomy, this is documented, and the reduced gallstone risk is factored into the decision. If you have known asymptomatic gallstones, we discuss the risks and benefits, provide written safety information, and ensure you understand warning signs to watch for. Subject to clinical approval, you can begin Mounjaro treatment from £124.99, with £20 off your first order using code Weightlossnew, and receive ongoing support from our UK-based clinical team throughout your weight loss journey.

Starting Your Assessment at Cured Pharmacy

To find out if our prescribers who will prescribe mounjaro with gallstones can approve your treatment, simply complete our free online consultation at curedpharmacy.com. The assessment takes under three minutes and covers your medical history, current medications, and weight loss goals. Our clinical team reviews your answers within 24 hours and provides a clear decision with personalised advice. If approved, your Mounjaro is dispensed from our UK-registered pharmacy (GPhC 9012511) and delivered discreetly to your door, with all pricing transparent upfront and no hidden fees.

Patient Scenarios: Who Will Prescribe Mounjaro With Gallstones in Practice

Real-world examples illustrate who will prescribe mounjaro with gallstones and under what circumstances. A patient with a history of asymptomatic gallstones detected on an ultrasound five years ago, now with a BMI of 34 kg/m² and no recent abdominal pain, is often considered a suitable candidate. The prescriber documents the gallstone history, advises on warning signs, and approves treatment with standard dose escalation and monitoring.

Conversely, a patient who experienced biliary colic two months ago and has not yet had their gallbladder removed may be advised to complete cholecystectomy first, then reassess for Mounjaro eligibility post-recovery. A patient who underwent cholecystectomy three years ago and has had no further biliary issues is typically considered low-risk and is often approved for tirzepatide without additional precautions beyond standard monitoring. These case-by-case decisions reflect the nuanced clinical judgement of prescribers who will prescribe mounjaro with gallstones responsibly, balancing the significant metabolic benefits of tirzepatide against individual risk factors [1][4].

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 11 September 2026]
2. Festi, D., Colecchia, A., Orsini, M., Sangermano, A., Sottili, S., Simoni, P., ... & Roda, E. (2008). Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). International Journal of Obesity, 32(9), 1343-1347. [accessed 11 September 2026]
3. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity. NICE technology appraisal guidance [TA1007]. Retrieved from https://www.nice.org.uk/guidance/ta1007 [accessed 11 September 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
5. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.